Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.09M.
ENTERPRISE VALUE (EV)
$3.09M
Cerenome, Inc.
Market Cap
$11.02M
Enterprise Value (EV)
$3.09M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cerenome, Inc. (CNSY) | $11.02M | $3.09M |
| BioVie Inc. (BIVI)vs › | $11.09M | $2.39M |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | $4.38M |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.19M | N/A |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.23M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.82M | $9.00M |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.25M | $803392.00 |
| Pluri Inc. (PLUR)vs › | $10.59M | $41.98M |
| Polyrizon Ltd. (PLRZ)vs › | $10.57M | $2.16M |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.56M | N/A |
Market Cap
$11.02M
Total Debt
$821000.00
Cash
$8.76M
Enterprise Value
$3.09M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
